Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06183567

The Effect of Sedoanalgesia and General Anaesthesia on Early Neurological Recovery in Acute Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy

The hypothesis of this study is that sedoanalgesia will provide better early neurological recovery than general anaesthesia in acute ischaemic stroke patients undergoing endovascular thrombectomy and to investigate the haemodynamic data of both anaesthetic methods.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Umraniye Education and Research Hospital

Istanbul, Umraniye, 34734, Turkey (Türkiye)

About this study

Endovascular mechanical thrombectomy (EMT) is the standard emergency treatment for patients presenting with acute ischemic stroke in the anterior circulation due to urgent large vessel occlusion and suitable for interventional procedures. However, despite reperfusion of the ischemia-affected area, some patients do not recover clinically. The reason for this is not known exactly. It is known that age and baseline function, which are thought to indicate brain reserve, affect the long-term outcome of stroke. Chronic hypertension, diabetes mellitus, dyslipidemia and coronary artery disease, which are associated with low brain reserve, are quite common in acute ischemic stroke patients.

There is controversy as to whether general anesthesia (GA) or sedoanalgesia (SA) should be used during EMT for acute ischemic stroke. There are not enough randomized trials addressing this question. Benefits of GA include airway preservation, pain control and potentially improved radiographic imaging and patient immobility for intervention. Conversely, GA is time-consuming and possibly associated with longer time for groin puncture and revascularization. In addition, hypotension may occur during GA, which carries a greater risk of ischemic damage. Advantages of SA may include shorter time to revascularization, fewer hemodynamic problems and the possibility of better neurological assessment during the procedure. The main arguments against SA are that patient movement can lead to procedural complications, higher radiation dose, the need for more contrast media and lack of airway control. Simonsen et al. compared general anesthesia and conscious sedation in patients with acute ischemic stroke undergoing endovascular treatment (GOLIATH) and showed that the choice of different anesthesia method can affect infarct area growth, clinical outcomes, and important physiological and anesthetic parameters.

Again, in the SIESTA (Sedation vs Intubation for Endovascular Stroke Treatment) study comparing sedation and intubation in endovascular stroke treatment, no significant difference was shown between both groups when early neurological recovery was compared (24th hour NIHSS). In this study, no superiority of conscious sedation over general anesthesia was demonstrated.

In the ESCAPE and SWIFT study, general anesthesia and conscious sedation were compared and conscious sedation was associated with better outcome than general anesthesia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of cerebral ischemic embolism within the first 6 hours
  • ASA 1-4
  • Body mass index below 30 kg m-2
  • NIHSS score ≥ 10
  • Presence of isolated/combined occlusion at any level of the anterior circulation internal carotid or middle cerebral artery

Exclusion criteria

  • Chronic renal failure
  • EF less than 40
  • Presence of intracranial hemorrhage
  • Previous known history of severe neurological disease
  • Presence of bleeding diathesis
  • Pre-procedure GCS ≤ 8 and intubated patients
  • Failure to clearly show the site of vascular occlusion on diagnostic imaging results
  • Clinical or imaging evidence of vascular occlusion that is not internal carotid artery or middle cerebral artery
  • Absence of gag reflex, loss of airway protective reflex, inadequate saliva swallowing
  • History of lung infection, advanced COPD or respiratory failure
  • Known history of aspiration due to vomiting,
  • Known history of difficult airway
  • In the presence of known intolerance or allergy to certain drugs for sedation, analgesia or both
  • Previously known carotid artery stenosis
  • Pregnant patients
  • Patients without consent

Treatment and study plan

Sedoanalgesia

Procedure

In Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy, the procedure was performed under sedoanalgesia. The procedure was continued with mean arterial pressure, heart rate, pulse oximetry and BIS monitoring.

General Anesthesia

Procedure

In Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy, the procedure was performed under general anesthesia. The procedure was continued with mean arterial pressure, heart rate, pulse oximetry and BIS monitoring.

Primary outcomes

  1. scoring systems of neurological findings

    Time frame: Before Endovascular Thrombectomy and after 48 hours

    NIHSS (National Institutes of Health Stroke Scale), Glasgow coma scale (GCS) and FOUR (Full Outline of UnResponsiveness) scores

  2. effects of both anesthesia management on hemodynamics during the procedure

    Time frame: Before the Endovascular Thrombectomy procedure and until the end of the recovery period (4 hours)

    Mean arterial pressure, heart rate

Secondary outcomes

  1. early neurological outcome findings

    Time frame: 48 hours

    hemiparesis, hemiplegia, aphasia, facial paralysis

  2. mortality and morbidity

    Time frame: hospitalization days

    exitus,discharge to home or palliative unit

Sponsors and collaborators

Lead sponsor

Umraniye Education and Research Hospital

Other Gov

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Dec 27, 2023
Registry last updated
Nov 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.